Eli Lilly and Company

Clinical Research Lead - Immunology, Neurodegeneration, Cardiometabolic Health, Investigator Engagement

Chester, Maryland, United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, BiotechnologyIndustries

Employment Type

Full time

Purpose

The Clinical Research Lead (CRL) is a strategic, field-based scientific leader responsible for driving the execution of Lilly clinical trials through exceptional investigator engagement and site performance management. This role is pivotal in ensuring Lilly’s portfolio is prioritized at high-performing sites and that trials are delivered with quality, speed, and insight.

CRLs combine deep therapeutic and scientific knowledge with strategic agility to influence investigators, elevate protocol understanding, and co-develop tailored enrollment strategies in existing and new therapeutic areas. They serve as trusted partners to investigators—building strong, enduring relationships that improve return on enrollment and position Lilly as the sponsor of choice.

CRLs partner closely with internal Lilly teams (including Clinical Development and Medical Affairs) to ensure that insights from the field shape development strategies and that development strategies are delivered with operational excellence and scientific clarity.

Where applicable the CRL may also represent Investigator Engagement with Regulatory and External Bodies and help shape the country-level clinical trial landscape.

Primary Responsibilities

Clinical Investigator Management

  • Accountable for the full spectrum of investigator engagement from identification and qualification through enrollment, and support database lock, and study closeout
  • Serve as a clinical trial scientific ambassador, ensuring investigators deeply understand protocol intent, scientific rationale, and patient eligibility requirements
  • Develop and sustain strategic, high-trust relationships with investigators that span trials and therapeutic areas
  • Influence enrollment by co-creating tailored recruitment strategies aligned with site capabilities, patient population realities, and study objectives
  • Proactively find opportunities to reach new patients, accelerate enrollment and increase impact at priority sites, including for example, novel site models, community-based research initiatives etc
  • Capture and elevate critical insights from sites to optimize feasibility, protocol design, and study conduct

Clinical Trial Management

  • Lead site-level strategy and risk planning to ensure strong and predictable enrollment and data delivery
  • Leverage performance metrics to anticipate issues, intervene decisively, and maintain momentum toward clinical milestones
  • Drive inspection readiness as a continuous discipline across sites
  • Collaborate across functions and with vendor partners to resolve operational barriers, ensuring delivery with speed and quality
  • Maintain advanced understanding of local treatment paradigms and standard of care to influence strategic country/site selection and protocol localization
  • Provide oversight and quality assurance for vendor monitoring, escalating risks proactively
  • Where applicable, lead end-to-end management of Post-Marketing Safety Studies in compliance with local regulations

Business Management and Engagement

  • Cultivate

Skills

Clinical trial execution
Investigator engagement
Site performance management
Therapeutic knowledge
Scientific knowledge
Enrollment strategies
Relationship building
Clinical Development
Medical Affairs
Regulatory affairs

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI